The cancer stem-cell signaling network and resistance to therapy
Amancio Carnero(Instituto de Salud Carlos III), Matilde E. Lleonart(Universitat Autònoma de Barcelona), Yoelsis Garcia‐Mayea(Universitat Autònoma de Barcelona), Isabel T. Rubio(Clinica Universidad de Navarra), Juan Lorente(Vall d'Hebron Institut de Recerca), Cristina Mir(Vall d'Hebron Institut de Recerca)
Cited by 155
Related Papers
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|544